Наша группа организует более 3000 глобальных конференций Ежегодные мероприятия в США, Европе и США. Азия при поддержке еще 1000 научных обществ и публикует более 700 Открытого доступа Журналы, в которых представлены более 50 000 выдающихся деятелей, авторитетных учёных, входящих в редколлегии.
Журналы открытого доступа набирают больше читателей и цитируемости
700 журналов и 15 000 000 читателей Каждый журнал получает более 25 000 читателей
Lin Xu
In chronic kidney disease (CKD) patients, vascular calcification (VC) and cardiac valve calcification (CVC) are the major reasons of increased risk of cardiovascular events. Originally thought to be a passive kind of dead or dying cells, VC and CVC have since been identified as a disease caused by an active and highly controlled cellular process. Several of the processes implicated in VC have recently been identified, and many of them may be exacerbated in CKD patients. FGF-23/Klotho axis, Wnt pathways, PI3K/Akt signalling, P38MAPK signalling pathway, and microRNAs, in particular, have been demonstrated to be disturbed in CKD patients and may have a role in vascular calcification. Moreover, multiple researches confirmed the hazards of CVC in CKD patients as well as the molecular processes behind it. The purpose of this review is to describe the risk variables and pathophysiological processes that may be implicated in the relationship among CKD and VC and CVC development.